SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-013707
Filing Date
2023-04-20
Accepted
2023-04-20 16:47:26
Documents
13
Period of Report
2023-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20230415.htm   iXBRL 8-K 140166
2 EX-3.1 tcon-ex3_1.htm EX-3 23569
  Complete submission text file 0000950170-23-013707.txt   289946

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20230415_pre.xml EX-101.PRE 9848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20230415_lab.xml EX-101.LAB 13351
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20230415.xsd EX-101.SCH 2481
7 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20230415_htm.xml XML 4731
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 23833718
SIC: 2836 Biological Products, (No Diagnostic Substances)